GL1X · GenesisL1 explorer

MolNFT v1 · #31692 · protein

Structure of mammalian C3 with an intact thioester at 3A resolution

2B39: “Structure of mammalian C3 with an intact thioester at 3A resolution”. X-ray diffraction, 2 ligands (NAG, BMA), 20 pockets (best druggability 0.82). MolNFT v1 #31692 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2B39
Type
protein
Length
3,220 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C3
UniProt
Q2UVX4
Ligands
NAG, BMA
Pockets
20 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 19% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BC3protein161019% helix, 32% strandQ2UVX4

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16490.820.8782empty
28930.800.8293empty
39390.800.8189empty
47990.790.8369empty
52580.790.9142empty

Interfaces

1 interface between chains.

  • A–B · 1084 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 26 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • Q2UVX4 · AlphaFold monomer V2.0 prediction for complement C3 (Q2UVX4) · a predicted model of the same protein · chain B against A, TM-score 0.67

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.